PreveCeutical Medical Inc. (OTCMKTS:PRVCF – Get Rating) was the recipient of a significant growth in short interest in July. As of July 15th, there was short interest totalling 3,800 shares, a growth of 850.0% from the June 30th total of 400 shares. Based on an average daily trading volume, of 75,600 shares, the short-interest ratio is presently 0.1 days.
PreveCeutical Medical Stock Performance
OTCMKTS PRVCF traded down $0.00 during mid-day trading on Friday, reaching $0.02. 10,257 shares of the stock were exchanged, compared to its average volume of 74,034. The business's 50 day moving average is $0.02 and its 200-day moving average is $0.02. PreveCeutical Medical has a 1 year low of $0.01 and a 1 year high of $0.03.
Get
PreveCeutical Medical alerts:
About PreveCeutical Medical
(Get Rating)
PreveCeutical Medical Inc, a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; BSV Peptide Program for targeting cancer progression; Non-Addictive Analgesic for pain management; and Dual Gene Therapy for type 2 diabetes and obesity.
Further Reading
- Get a free copy of the StockNews.com research report on PreveCeutical Medical (PRVCF)
- Windfall Profits Have Exxon Mobil On Track For New Highs
- Adobe Stock, Why some investors are bullish, and others are not
- Was The Market Wrong On Etsy Again, As Shares Gain Post Earnings?
- Is Google The Buy Of The Summer?
- Should CVS Health Be in Your Portfolio?
Receive News & Ratings for PreveCeutical Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PreveCeutical Medical and related companies with MarketBeat.com's FREE daily email newsletter.
PreveCeutical Medical Inc. (OTCMKTS:PRVCF – Get Rating) was the recipient of a significant growth in short interest in July. As of July 15th, there was short interest totalling 3,800 shares, a growth of 850.0% from the June 30th total of 400 shares. Based on an average daily trading volume, of 75,600 shares, the short-interest ratio is presently 0.1 days.
PreveCeutical Medical Inc.(OTCMKTS：PRVCF-GET Rating)是7月份空頭股數顯著增長的接受者。截至7月15日，空頭股數共有3,800股，較6月30日的400股增長850.0%。以日均成交量七萬五千六百股計算，目前短息比率為零點一天。
PreveCeutical Medical Stock Performance
OTCMKTS PRVCF traded down $0.00 during mid-day trading on Friday, reaching $0.02. 10,257 shares of the stock were exchanged, compared to its average volume of 74,034. The business's 50 day moving average is $0.02 and its 200-day moving average is $0.02. PreveCeutical Medical has a 1 year low of $0.01 and a 1 year high of $0.03.
OTCMKTS PRVCF在週五午盤交易中下跌0.00美元，至0.02美元。該股成交量為10,257股，而平均成交量為74,034股。該業務的50日移動均線切入位在0.02美元，200日移動均線切入位在0.02美元。PreveCeutical Medical的一年低點為0.01美元，一年高位為0.03美元。
Get
PreveCeutical Medical
alerts:
About PreveCeutical Medical
PreveCeutical Medical Inc, a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; BSV Peptide Program for targeting cancer progression; Non-Addictive Analgesic for pain management; and Dual Gene Therapy for type 2 diabetes and obesity.
PreveCeutical Medical Inc.是一家健康科學公司，致力於利用有機和天然相同的產品開發預防和治療方法的選擇。其流水線產品包括大麻素Sol-Gel給藥系統，這是一種基於大麻素的鼻腦給藥系統，可以緩解包括疼痛、炎症、癲癇和神經疾病在內的各種適應症；針對癌症進展的BSV多肽計劃；用於止痛的非成癮性止痛藥；以及用於治療2型糖尿病和肥胖症的雙基因療法。
Further Reading
- Get a free copy of the StockNews.com research report on PreveCeutical Medical (PRVCF)
- Windfall Profits Have Exxon Mobil On Track For New Highs
- Adobe Stock, Why some investors are bullish, and others are not
- Was The Market Wrong On Etsy Again, As Shares Gain Post Earnings?
- Is Google The Buy Of The Summer?
- Should CVS Health Be in Your Portfolio?
- 免費獲取StockNews.com關於PreveCeutical Medical(PRVCF)的研究報告
- 暴利使埃克森美孚有望創下新高
- Adobe股票，為什麼一些投資者看漲，另一些投資者則不看好
- 隨着股價在盈利後上漲，Etsy的市場又錯了嗎？
- 谷歌是今夏的最佳選擇嗎？
- CVS Health是否應該在您的投資組合中？
Receive News & Ratings for PreveCeutical Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PreveCeutical Medical and related companies with MarketBeat.com's FREE daily email newsletter.
接受《預科醫學日報》的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對PreveCeutical Medical及相關公司的最新新聞和分析師評級的每日簡要摘要。
